| http://www.w3.org/ns/prov#value | - Earlier preclinical studies of Starpharma???s DEP???-Docetaxel demonstrated the significantly superior anti-cancer effectiveness of the product compared to Taxotere?? across a range of important cancer types including breast, prostate, lung and ovarian cancer.
|
